MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
19.90
-0.09 (-0.45%)
At close: Jun 26, 2026, 4:00 PM EDT
20.25
+0.35 (1.76%)
After-hours: Jun 26, 2026, 7:46 PM EDT
MLTX Market Cap
MLTX has a market cap or net worth of $1.64 billion as of June 26, 2026. Its market cap has decreased by -41.36% in one year.
Market Cap
1.64B
Enterprise Value
1.39B
1-Year Change
-41.36%
Ranking
Category
Stock Price
$19.90
Market Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $1.64B, an increase of 45,592.34%. That is a compound annual growth rate of 306.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 1.64B | 74.77% |
| Dec 31, 2025 | 940.70M | -72.45% |
| Dec 31, 2024 | 3.41B | -5.66% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
| Feb 14, 2022 | 3.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zenas BioPharma | 1.56B |
| Septerna | 1.56B |
| Immunocore Holdings | 1.55B |
| Savara | 1.53B |
| Ardelyx | 1.50B |
| Maze Therapeutics | 1.50B |
| Ascentage Pharma Group International | 1.46B |
| MapLight Therapeutics | 1.45B |